Fatigue and disrupted sleep-wake patterns in patients with cancer: A shared mechanism

Clinical Journal of Oncology Nursing

Volumn 16, Issue 2, 2012, Pages

  Wu, Horng Shiuann ^a   Davis, Jean E ^a   Natavio, Teofanes ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; FATIGUE; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MIDDLE AGED; NEOPLASM; NURSING EDUCATION; PATHOPHYSIOLOGY; SLEEP; WAKEFULNESS;

ADULT; CIRCADIAN RHYTHM; EDUCATION, NURSING, CONTINUING; FATIGUE; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; NEOPLASMS; PITUITARY-ADRENAL SYSTEM; SLEEP; WAKEFULNESS;

EID: 84859182820     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/12.CJON.E56-E68     Document Type: Article

References (105)

1. Abercrombie, H.C., Giese-Davis, J., Sephton, S., Epel, E.S., Turner-Cobb, J.M., & Spiegel, D. (2004). Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology, 29, 1082-1092. doi:10.1016/j.psyneuen.2003.11.003
2. Aistars, J. (1987). Fatigue in the cancer patient: A conceptual approach to a clinical problem. Oncology Nursing Forum, 14, 25-30.
3. Alexander, S., Minton, O., Andrews, P., & Stone, P. (2009). A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. European Journal of Cancer, 45, 384-392.
4. Andrews, P., Morrow, G., Hickok, J., Roscoe, J., & Stone, P. (2004). Mechanisms and models of fatigue associated with cancer and its treatment: Evidence from preclinical and clinical studies. In J. Armes, M. Krishnasamy, & I. Higginson (Eds.), Fatigue in cancer (pp. 51-87). New York, NY: Oxford.
5. Andrykowski, M.A., Curran, S.L., & Lightner, R. (1998). Off-treatment fatigue in breast cancer survivors: A controlled comparison. Journal of Behavioral Medicine, 21, 1-18.
6. Barbera, L., Seow, H., Howell, D., Sutradhar, R., Earle, C., Liu, Y.,... Dudgeon, D. (2010). Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer, 116, 5767-5776. doi:10.1002/cncr.25681
7. Beck, S.L., Berger, A.M., Barsevick, A.M., Wong, B., Stewart, K.A., & Dudley, W. (2010). Sleep quality after initial chemotherapy for breast cancer. Supportive Care in Cancer, 18, 679-689.
8. Berger, A.M. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 25, 51-62.
9. Berger, A.M., & Farr, L. (1999). The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncology Nursing Forum, 26, 1663-1671.
10. Berger, A.M., & Higginbotham, P. (2000). Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncology Nursing Forum, 27, 1443-1448.
11. Bower, J., Ganz, P., Aziz, N., Olmstead, R., Irwin, M., & Cole, S. (2007). Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids. Brain, Behavior, and Immunity, 21, 251-258.
12. Bower, J.E. (2007). Cancer-related fatigue: Links with inflammation in cancer patients and survivors. Brain, Behavior, and Immunity, 21, 863-871. doi:S0889-1591(07)00077-3
13. Bower, J.E., Ganz, P.A., & Aziz, N. (2005). Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosomatic Medicine, 67, 277-280.
14. Bower, J.E., Ganz, P.A., Aziz, N., & Fahey, J.L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64, 604-611.
15. Bower, J.E., Ganz, P.A., Dickerson, S.S., Petersen, L., Aziz, N., & Fahey, J.L. (2005). Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology, 30, 92-100.
16. Brown, M. R., Fisher, L. A., Spiess, J., Rivier, C., Rivier, J., & Vale, W. (1982). Corticotropin-releasing factor: Actions on the sympathetic nervous system and metabolism. Endocrinology, 111, 928-931. doi:10.1210/endo-111-3-928
17. Byar, K.L., Berger, A.M., Bakken, S.L., & Cetak, M.A. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life [Online exclusive]. Oncology Nursing Forum, 33, E18-E26. doi:10.1188/06.ONF.E18-E26
18. Carlson, L.E., Campbell, T.S., Garland, S.N., & Grossman, P. (2007). Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. Journal of Behavioral Medicine, 30, 45-58.
19. Caudeell, K. (2000). Psychoneuroimmunology: Foundations for mind-body interactions. In W. Winningham & M. Barton-Burke (Eds.), Fatigue in cancer: A multidimensional approach (pp. 123-149). Boston, MA: Jones and Bartlett.
20. Cella, D., Davis, K., Breitbart, W., & Curt, G. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19, 3385-3391.
21. Cheng, K., & Lee, D. (2011). Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Critical Reviews in Oncology/Hematology, 78, 127-137. doi:10.1016/j.critrevonc.2010.03.002
22. Cleare, A.J., & Wessely, S.C. (1996). Chronic fatigue syndrome: A stress disorder? British Journal of Hospital Medicine, 55, 571-574.
23. Cleeland, C.S., Bennett, G.J., Dantzer, R., Dougherty, P.M., Dunn, A.J., Meyers, C.A.,... Lee, B.N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919-2925. doi:10.1002/cncr.11382
24. Cleeland, C.S., Mendoza, T.R., Wang, X.S., Chou, C., Harle, M.T.,... Morrissey, M. (2000). Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer, 89, 1634-1646. doi:10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V
25. Crofford, L.J., Young, E.A., Engleberg, N.C., Korszun, A., Brucksch, C.B., McClure, L.A.,... Demitrack, M.A. (2004). Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain, Behavior, and Immunity, 18, 314-325. doi:10.1016/j.bbi.2003.12.011
26. Culebras, A., Lee-Chiong, T.L., Sateia, M.J., & Carueadon, M.A. (2002). Sleep medicine. Philadelphia, PA: Hanley and Belfus.
27. Curt, G.A., Breitbart, W., Cella, D., Groopman, J.E., Horning, S.J., Itri, L.M.,... Vogelzang, N.J. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist, 5, 353-360.
28. Czeisler, C.A., Duffy, J.F., Shanahan, T.L., Brown, E.N., Mitchell, J.F., Rimmer, D.W.,... Kronauer, R.E. (1999). Stability, precision, and near-24-hour period of the human circadian pacemaker. Science, 284, 2177-2181. doi:10.1126/science.284.5423.2177
29. Dallman, M.F. (1993). Stress update: Adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress. Trends in Endocrinology and Metabolism, 4, 62-69. doi:S1043-2760(05)80017-7
30. Davidson, J.R., MacLean, A.W., Brundage, M.D., & Schulze, K. (2002). Sleep disturbance in cancer patients. Social Science and Medicine, 54, 1309-1321.
31. Demitrack, M.A. (1997). Neuroendocrine correlates of chronic fatigue syndrome: A brief review. Journal of Psychiatric Research, 31, 69-82.
32. Demitrack, M.A., & Crofford, L.J. (1998). Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Annals of the New York Academy of Sciences, 840, 684-697.
33. Demitrack, M.A., Dale, J.K., Straus, S.E., Laue, L., Listwak, S.J., Kruesi, M.J.,... Gold, P.W. (1991). Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. Journal of Clinical Endocrinology and Metabolism, 73, 1224-1234. doi:10.1210/jcem-73-6-1224
34. de Souza, L., Benedito-Silva, A., Pires, M., Poyares, D., Tufik, S., & Calil, H. (2003). Further validation of actigraphy for sleep studies. Sleep, 26, 81-85.
35. Dinan, T.G., Majeed, T., Lavelle, E., Scott, L.V., Berti, C., & Behan, P. (1997). Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology, 22, 261-267.
36. Dodd, M.J., Miaskowski, C., & Lee, K.A. (2004). Occurrence of symptom clusters. Journal of the National Cancer Institute Monographs, 32, 76-78.
37. Enderlin, C., Coleman, E., Cole, C., Richards, K., Kennedy, R., Goodwin, J.,... Mack, K. (2011). Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer [Online Exclusive]. Oncology Nursing Forum, 38, E314-E325. doi:10.1188/11.ONF.E314-E325
38. Fernstrom, J., & Fernstrom, M. (2006). Exercise, serum free tryptophan, and central fatigue. Journal of Nutrition, 136(Suppl.2), 553S-559S.
39. Flechtner, H., & Bottomley, A. (2003). Fatigue and quality of life: Lessons from the real world. Oncologist, 8(Suppl. 1), 5-9.
40. Fleming, L., Gillespie, S., & Espie, C.A. (2010). The development and impact of insomnia on cancer survivors: A qualitative analysis. Psycho-Oncology, 19, 991-996. doi:10.1002/pon.1652
41. Fortner, B.V., Stepanski, E.J., Wang, S.C., Kasprowicz, S., & Durrence, H.H. (2002). Sleep and quality of life in breast cancer patients. Journal of Pain and Symptom Management, 24, 471-480.
42. Fukuda, K., Straus, S.E., Hickie, I., Sharpe, M.C., Dobbins, J. G., & Komaroff, A. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine, 121, 953-959.
43. Fuller, P., Gooley, J., & Saper, C. (2006). Neurobiology of the sleep-wake cycle: Sleep architecture, circadian regulation, and regulatory feedback. Journal of Biological Rhythms, 21, 482-493.
44. Giorgio, A.D., Hudson, M., Jerjes, W., & Cleare, A. (2005). 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Psychosomatic Medicine, 67, 433-440.
45. Griep, E.N., Boersma, J.W., & de Kloet, E.R. (1993). Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. Journal of Rheumatology, 20, 469-474.
46. Grunfeld, E.A., & Cooper, A.F. (2010). A longitudinal qualitative study of the experience of working following treatment for gynaecological cancer. Psycho-Oncology, 21, 82-89.
47. Heim, C., Ehlert, U., & Hellhammer, D.H. (2000). The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology, 25, 1-35.
48. Jakeman, P.M., Hawthorne, J.E., Maxwell, S.R., Kendall, M.J., & Holder, G. (1994). Evidence for downregulation of hypothalamic 5-hydroxytryptamine receptor function in endurance-trained athletes. Experimental Physiology, 79, 461-464.
49. Johansson, E., Wilson, B., Brunton, L., Tishelman, C., & Molassiotis, A. (2010). Symptoms before, during, and after 14 months after the beginning of treatment as percieved by patients with lymphoma [Online Exclusive]. Oncology Nursing Forum, 37, E105-E113. doi:10.1188/10.ONF.E105-E113
50. Kirkova, J., Rybicki, L., Walsh, D., Aktas, A., Davis, M.P., & Karafa, M.T. (2010). The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. American Journal of Hospice and Palliative Medicine, 28, 350-355. doi:10.1177/1049909110391464
51. Kuo, H.H., Chiu, M.J., Liao, W.C., & Hwang, S.L. (2006). Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. Journal of the Formosan Medical Association, 105, 64-69. doi:10.1016/S0929-6646(09)60110-8
52. Langeveld, N.E., Grootenhuis, M.A., Voute, P.A., de Haan, R.J., & van den Bos, C. (2003). No excess fatigue in young adult survivors of childhood cancer. European Journal of Cancer, 39, 204-214.
53. Lee, B.N., Dantzer, R., Langley, K.E., Bennett, G.J., Dougherty, P.M., Dunn, A.J.,... Cleeland, C.S. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11, 279-292. doi:10.1159/000079408
54. Leonard, B.E. (2010). The concept of depression as a dysfunction of the immune system. Current Immunology Reviews, 6, 205-212.
55. Lombardi, V.C., Ruscetti, F.W., Das Gupta, J., Pfost, M.A., Hagen, K.S., Peterson, D.L.,... Mikovits, J.A. (2009). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, 326, 585-589.
56. McEwen, B.S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171-179.
57. McEwen, B.S., Biron, C.A., Brunson, K.W., Bulloch, K., Chambers, W.H., Dhabhar, F.S.,... Weiss, J.M. (1997). The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Research Reviews, 23, 79-133.
58. Miaskowski, C., & Lee, K.A. (1999). Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: A pilot study. Journal of Pain Symptom Management, 17, 320-332. doi:S0885-3924(99)00008-1
59. Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2008). A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. Journal of the National Cancer Institute, 100, 1155-1166.
60. Mormont, M.C., Waterhouse, J., Bleuzen, P., Giacchetti, S., Jami, A., Bogdan, A.,... Levi, F. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clinical Cancer Research, 6, 3038-3045.
61. Morrow, G., Hickok, J., Roscoe, J., Raubertas, R., Andrews, P., Flynn P.,... King, D. (2003). Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology, 21, 4635-4641.doi:10.1200/JCO.2003.04.070
62. Okuyama, T., Tanaka, K., Akechi, T., Kugaya, A., Okamura, H., Nishiwaki, Y.,... Uchitomi, Y. (2001). Fatigue in ambulatory patients with advanced lung cancer: Prevalence, correlated factors, and screening. Journal of Pain and Symptom Management, 22, 554-564. doi:10.1016/S0885-3924(01)00305-0
63. Oldstone, M.B., Sinha, Y.N., Blount, P., Tishon, A., Rodriguez, M., von Wedel, R.,... Lampert, P.W. (1982). Virus-induced alterations in homeostasis: Alteration in differentiated functions of infected cells in vivo. Science, 218, 1125-1127. doi:10.1126/science.7146898
64. Palesh, O., Zeitzer, J., Conrad, A., Giese-Davis, J., Mustian, K., Popek,... Spiegel, D. (2008). Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. Journal of Clinical Sleep Medicine, 4, 441-449.
65. Palesh, O.G., Collie, K., Batiuchok, D., Tilston, J., Koopman, C., Perlis, M.L.,... Spiegel, D. (2007). A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biological Psychology, 75, 37-44. doi:10.1016/j.biopsycho.2006.11.002
66. Parker, K.P., Bliwise, D.L., Ribeiro, M., Jain, S.R., Vena, C. I., Kohles-Baker, M.K.,... Harris, W.B. (2008). Sleep-wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. Journal of Clinical Oncology, 26, 2464-2472.
67. Payne, J., Piper, B., Rabinowitz, I., & Zimmerman, B. (2006). Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: A pilot study. Oncology Nursing Forum, 33, 775-783. doi:10.1188/06.ONF.775-783
68. Payne, J.K. (2004). A neuroendocrine-based regulatory fatigue model. Biological Research for Nursing, 6, 141-150.
69. Portenoy, R.K., & Itri, L.M. (1999). Cancer-related fatigue: Guidelines for evaluation and management. Oncologist, 4, 1-10.
70. Posener, J.A., Schildkraut, J.J., Samson, J.A., & Schatzberg, A.F. (1996). Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology, 21, 33-38.
71. Poteliakhoff, A. (1981). Adrenocortical activity and some clinical findings in acute and chronic fatigue. Journal of Psychosomatic Research, 25, 91-95.
72. Powell, L.H., Lovallo, W.R., Matthews, K.A., Meyer, P., Midgley, A.R., Baum, A.,... Ory, M.G. (2002). Physiologic markers of chronic stress in premenopausal, middle-aged women. Psychosomatic Medicine, 64, 502-509.
73. Pud, D., Ben Ami, S., Cooper, B.A., Aouizerat, B.E., Cohen, D., Radiano, R.,... Miaskowski, C. (2008). The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. Journal of Pain and Symptom Management, 35, 162-170. doi:10.1016/j.jpainsymman.2007.03.010
74. Quick, M., & Fonteyn, M. (2005). Development and implementation of a clinical survey for cancer-related fatigue assessment. Clinical Journal of Oncology Nursing, 9, 435-439. doi:10.1188/05.CJON.435-439
75. Raison, C.L., & Miller, A.H. (2003). When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. American Journal of Psychiatry, 160, 1554-1565.
76. Redeker, N.S., Lev, E.L., & Ruggiero, J. (2000). Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Scholarly Inquiry for Nursing Practice, 14, 275-290.
77. Reinertsen, K.V., Cvancarova, M., Loge, J.H., Edvardsen, H., Wist, E., & Fossa, S.D. (2010). Predictors and course of chronic fatigue in long-term breast cancer survivors. Journal of Cancer Survivorship, 4, 405-414. doi:10.1007/s11764-010-0145-7
78. Roscoe, J., Morrow, G., Hickok, J., Mustian, K., Griggs, J., Matteson, S.,... Smith, B. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment, 89, 243-249. doi:10.1007/s10549-004-2175-1
79. Roscoe, J.A., Kaufman, M.E., Matteson-Rusby, S.E., Palesh, O.G., Ryan, J.L., Kohli, S.,... Morrow, G.R. (2007). Cancer-related fatigue and sleep disorders. Oncologist, 12(Suppl. 1), 35-42. doi:10.1634/theoncologist.12-S1-35
80. Rosedale, M., & Fu, M.R. (2010). Confronting the unexpected: Temporal, situational, and attributive dimensions of distressing symptom experience for breast cancer survivors [Online Exclusive]. Oncology Nursing Forum, 37, E28-E33. doi:10.1188/10.ONF.E28-E33
81. Sadler, I.J., Jacobsen, P.B., Booth-Jones, M., Belanger, H., Weitzner, M.A., & Fields, K.K. (2002). Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. Journal of Pain and Symptom Management, 23, 406-416. doi:10.1016/S0885-3924(02)00388-3
82. Sarna, L. (1993). Correlates of symptom distress in women with lung cancer. Cancer Practice, 1, 21-28.
83. Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C.M. (2001). Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep, 24, 583-590.
84. Scott, J., Lasch, K., Barsevick, A., & Piault-Louis, E. (2011). Patients' experiences with cancer-related fatigue: A review and synthesis of qualitative research [Online exclusive]. Oncology Nursing Forum, 38, E191-E203. doi:10.1188/10.ONF.E191-E203
85. Scott, L.V., & Dinan, T.G. (1998). Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. Journal of Affective Disorders, 47(1-3), 49-54.
86. Scott, L.V., & Dinan, T.G. (1999). The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis. Functional Neurology, 14, 3-11.
87. Scott, L.V., Medbak, S., & Dinan, T.G. (1998a). Blunted adreno-corticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatrica Scandinavica, 97, 450-457. doi:10.1111/j.1600-0447.1998.tb10030.x
88. Scott, L.V., Medbak, S., & Dinan, T.G. (1998b). The low dose ACTH test in chronic fatigue syndrome and in health. Clinical Endocrinology, 48(6), 733-737. doi:10.1046/j.1365-2265.1998.00418.x
89. Scott, L.V., Teh, J., Reznek, R., Martin, A., Sohaib, A., & Dinan, T.G. (1999). Small adrenal glands in chronic fatigue syndrome: A preliminary computer tomography study. Psychoneuro-endocrinology, 24, 759-768. doi:10.1016/S0306-4530(99)00028-1
90. Sephton, S., & Spiegel, D. (2003). Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain, Behavior, and Immunity, 17, 321-328.
91. Sephton, S.E., Sapolsky, R.M., Kraemer, H.C., & Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survial. Journal of the National Cancer Institute, 92, 994-1000. doi:10.1093/jnci/92.12.994
92. Silberfarb, P.M., Hauri, P.J., Oxman, T.E., & Lash, S. (1985). Insomnia in cancer patients. Social Science and Medicine, 20, 849-850. doi:10.1016/0277-9536(85)90340-5
93. Silberfarb, P.M., Hauri, P.J., Oxman, T.E., & Schnurr, P. (1993). Assessment of sleep in patients with lung cancer and breast cancer. Journal of Clinical Oncology, 11, 997-1004.
94. Spiegel, D., & Sephton, S.E. (2001). Psychoneuroimmune and endocrine pathways in cancer: Effects of stress and support. Seminars in Clinical Neuropsychiatry, 6, 252-265. doi:10.1053/scnp.2001.26995
95. Steiger, A. (2002). Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Medicine Reviews, 6, 125-138.
96. Sternberg, E.M. (1993). Hyperimmune fatigue syndromes: Diseases of the stress response? Journal of Rheumatology, 20, 418-421.
97. Touitou, Y., Bogdan, A., Levi, F., Benavides, M., & Auzeby, A. (1996). Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens. British Journal of Cancer, 74, 1248-1252.
98. Touitou, Y., Levi, F., Bogdan, A., Benavides, M., Bailleul, F., & Misset, J. (1995). Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. Journal of Cancer Research and Clinical Oncology, 121, 181-188.
99. Van Belle, S., Paridaens, R., Evers, G., Kerger, J., Bron, D., Foubert, J.,... Rosillon, D. (2005). Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: Proposal for use as a screening tool. Supportive Care in Cancer, 13, 246-254.
100. van der Pompe, G., Antoni, M.H., & Heijnen, C.J. (1996). Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology, 21, 361-374.
101. Vercoulen, J., Swanink, C., Zitman, F., Vreden, S., Hoofs, M., Fennis, J.,... Bleijenberg, G. (1996). Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet, 347, 858-861.
102. Vgontzas, A.N., Bixler, E.O., Wittman, A.M., Zachman, K., Lin, H.M., Vela-Bueno, A.,... Chrousos, G.P. (2001). Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: Clinical implications. Journal of Clinical Endocrinology and Metabolism, 86, 1489-1495.
103. Vgontzas, A.N., & Chrousos, G.P. (2002). Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders. Endocrinology and Metabolism Clinics of North America, 31, 15-36.
104. Weninger, S., Dunn, A., Muglia, L., Dikkes, P., Miczek, K., Swiergiel, A.,... Majzoub, J. (1999). Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proceedings of the National Academy of Sciences of the United States of America, 96, 8283-8288.
105. Zerouali, Y., Jemel, B., & Godbout, R. (2010). The effects of early and late night partial sleep deprivation on automatic and selective attention: An ERP study. Brain Research, 1308, 87-99. doi:10.1016/j.brainres.2009.09.090